Overview
This study aims to determine the participation rate of patients with registered rare cancers in clinical research.
Description
Data collection includes:
- Clinical characteristics (diagnosis, treatment information, primary/metastatic sites, staging, gender/age)
- Survival information (diagnosis date, recurrence date, death date, disease progression)
- Pathological information (diagnosis, genomic information)
Eligibility
Inclusion Criteria:
- Adults aged ≥19 years
- Confirmed rare cancer
- Life expectancy ≥3 months
Exclusion Criteria:
-Serious or unstable medical/psychiatric conditions